STOCK TITAN

Scinai Immunotherapeutics Ltd. (SCNI) Free Cash Flow by Year

SCNI

Scinai Immunotherapeutics Ltd. recorded an outflow of $6.1M in free cash flow in fiscal year 2025. This represents an increase of 4.6% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Scinai Immunotherapeutics Ltd. has filed alongside them.

FY2025 annual
Free Cash Flow -$6.1M
YoY +4.6%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SCNI Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2210-KFY2110-K
Free Cash Flow-$6.1M+4.6%-$6.3M+36.7%-$10.0M-23.7%-$8.1M-7.1%-$7.6M

SCNI Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'2410-QQ4'2310-KQ2'2310-QQ1'2310-QQ4'2210-KQ2'2210-QQ1'2210-QQ4'2110-K
Free Cash FlowN/AN/AN/AN/AN/A-$3.3M+12.1%-$3.1M-88.5%N/A-$3.7M-$1.6MN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Scinai Immunotherapeutics Ltd. financials

Frequently Asked Questions

What was Scinai Immunotherapeutics Ltd.'s free cash flow in fiscal year 2025?

Scinai Immunotherapeutics Ltd. recorded an outflow of $6.1M in free cash flow in fiscal year 2025.

How fast is Scinai Immunotherapeutics Ltd.'s free cash flow growing?

Scinai Immunotherapeutics Ltd. (SCNI) free cash flow rose by 4.6% year over year, from -$6.3M to -$6.1M in fiscal year 2025.

How has Scinai Immunotherapeutics Ltd.'s free cash flow changed over the years?

Across the 5 fiscal years this page covers, Scinai Immunotherapeutics Ltd. (SCNI) free cash flow went from -$7.6M in fiscal year 2021 to -$6.1M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Scinai Immunotherapeutics Ltd. (SCNI) reported on that line in every period on record.